COMBINATION OF BRAF INHIBITOR, TALIMOGENE LAHERPAREPVEC, AND IMMUNE CHECKPOINT INHIBITOR… Application WO-2018075447-A1 World Intellectual Property Organisation (WIPO) 26 Apr 2018